Kent Imaging

Kent Imaging A leading innovator in oxygenation imaging with SnapshotNIR - advancing tissue assessment.

Kent's SnapshotNIR is the latest advancement in tissue oxygenation imaging. The cost effective and easy to use imaging device is completely non-invasive, eliminating the need for patient contact or the injected dyes required by other technologies. Instantly capture diagnostic insight into the availability of oxygenated blood in tissue. Providing improved decision making throughout the dynamic treatment pathway – before, during and after wound or surgical care.

Kent Imaging partners with JCare Medical Technology Co. Limited to bring advanced near-infrared tissue oxygenation imagi...
06/02/2026

Kent Imaging partners with JCare Medical Technology Co. Limited to bring advanced near-infrared tissue oxygenation imaging to the Asia-Pacific region.

“JCare's established presence and deep expertise in advanced wound care make them an ideal partner to reach clinicians in the Asia-Pacific area,” said Pierre Lemire, Chief Executive Officer of Kent Imaging. “Together, we are providing powerful, objective tissue viability data to more clinicians and patients, working towards the ultimate goal of improving patient outcomes.”

JCare Medical Technology Co. Limited, headquartered in Kowloon, Hong Kong, is a recognized market leader in the distribution of advanced wound care, compression therapy, and related medical technology products across Hong Kong and Macau.

"SnapshotNIR is a natural fit for our portfolio and our clinical partners," said Mr. Joe Lee, Managing Director of JCare Medical Technology. "In wound care and surgical settings, having objective, real-time data on tissue viability changes how clinicians approach treatment decisions. We are excited to introduce this technology to the Hong Kong and Macau markets and to work alongside Kent Imaging."

Read the full press release: https://hubs.la/Q04jQyKn0

This research focused on the use of near-infrared spectroscopy as a non-invasive method for assessing lower extremity pe...
05/29/2026

This research focused on the use of near-infrared spectroscopy as a non-invasive method for assessing lower extremity perfusion and contributing to the stratification of peripheral arterial disease severity.

Using SnapshotNIR, the authors explored how tissue oxygenation data may complement vascular assessment by offering timely, visual insight into oxygenation status, supporting clinical evaluation and decision-making without added patient burden.

Presented by Paul W. White, MD; Mariam Hashemi; Debarpan Das, MSc; Najratun N. Pinky, PhD; Jeffrey Niezgoda, MD; Richard F. Neville, MD

At SAWC Spring 2026

See more clinical posters: https://hubs.la/Q049TWCY0

62–76% better healing rates. 19,000+ wounds analyzed. 22 US states. Real clinicians. Real patients. Real results.The stu...
05/28/2026

62–76% better healing rates. 19,000+ wounds analyzed. 22 US states. Real clinicians. Real patients. Real results.

The study found that providers used SnapshotNIR for:

- care plan evaluation (92.98%)
- tissue oxygenation trending (66.65%)
- evaluation of the necessity and effectiveness of debridement (29.16%)
- microcirculation or vascular referral assessment (8.89%)

SnapshotNIR could provide rapid capture of objective data at point-of-care, allowing clinicians to make timely interventions. This means less reliance on subjective monitoring.

Get the full picture in our free Publication Guide → key findings, clinical applications, and what this means for wound care practice.

Download yours: https://hubs.la/Q04dMS7Q0

Image adapted from the publication: Kelso, M. R., Ohrt, A. R., Brunkan, E., Flynn, D., Riley, L., Tettelbach, W. H., Nayem Pinky, N., Das, D., Feight, J., & Niezgoda, J. (2025). Use of near infrared spectroscopy in post-acute care: Analysis of real-world clinical decision-making. Journal of Wound Care, 34(6 Suppl), S1–S10. https://hubs.la/Q04dMRmb0

05/26/2026

Bacterial burden in chronic wounds isn't always visible but it's always relevant.

SnapshotGLO uses bacterial autofluorescence imaging to detect bacteria at the point of care, helping clinicians make faster, more targeted treatment decisions for DFUs, VLUs, and other complex chronic wounds.

It is difficult to fight what you cannot see. The wound that looked clean and viable on week four might be losing the ba...
05/22/2026

It is difficult to fight what you cannot see. The wound that looked clean and viable on week four might be losing the battle beneath the surface. The Snapshot Suite shines a light on the colors of wound care to bridge the gap between clinical intuition and objective data.

SnapshotGLO can help you detect high bacterial loads in a wound, seen on the screen as a fluorescent "glow."

Cyan and red fluorescence may indicate harmful bacteria even when a patient isn’t presenting with typical signs and symptoms of infection.

This information allows for more targeted debridement, more effective cleansing, and more precise tissue culture decisions.

Read the full blog here: https://hubs.la/Q04fDr3X0

What does global collaboration look like in real-world wound care?This case from the Medical Mission 2026 to Grenada hig...
05/21/2026

What does global collaboration look like in real-world wound care?

This case from the Medical Mission 2026 to Grenada highlights how Dr. Jeffrey Niezgoda, CMO of Wound Care and Limb Preservation at Kent Imaging, and Dr. Tyler Sexton worked with local clinicians to support wound assessment using SnapshotGLO, which provides real-time bacterial autofluorescence imaging at the point of care.

📖 Read how SnapshotGLO supported clinical decision making for this case: https://hubs.la/Q04cdDZj0

Effective debridement isn’t about removing more tissue; it’s about removing the right tissue. Bacterial burden extends b...
05/19/2026

Effective debridement isn’t about removing more tissue; it’s about removing the right tissue.

Bacterial burden extends beyond what’s visible; clinical judgment alone can be challenged.

SnapshotGLO uses bacterial autofluorescence imaging to reveal areas of elevated bioburden (>10^4 colony-forming units/gram of tissue), helping clinicians confirm debridement adequacy with objective visual evidence.

Precision builds confidence for both the clinician and the patient.

See how clinicians are using SnapshotGLO to educate patients and guide treatment decisions in this case series: https://hubs.la/Q04bqjtw0

This case series examined how bacterial autofluorescence imaging can support debridement decisions in chronic wounds by ...
05/15/2026

This case series examined how bacterial autofluorescence imaging can support debridement decisions in chronic wounds by providing real-time visualization of bacterial presence that may not be evident through visual assessment alone.

The work demonstrated how SnapshotGLO can help guide targeted treatment, support clinical confidence, and inform follow-up care in complex wound environments.

Presented by:

Tyler Sexton, MD; Catherine Balavender; Christopher Barrett, DPM; Jeffrey Niezgoda, MD, FACHM, MAPWCA, CHWS

Presented at SAWC Spring 2026.

See more clinical posters: https://hubs.la/Q049TVs00

Kent Imaging and Roots Pharmaceutical Announce Distribution Agreement to Bring SnapshotNIR to the GCC and Iraq“Expansion...
05/14/2026

Kent Imaging and Roots Pharmaceutical Announce Distribution Agreement to Bring SnapshotNIR to the GCC and Iraq

“Expansion into this region represents a tremendous opportunity to bring meaningful change to patients living with complex wounds, vascular disease, and diabetic complications,” said Pierre Lemire, Chief Executive Officer of Kent Imaging.

Dr. Islam Zayed, CEO of Roots Pharmaceutical commented, “SnapshotNIR directly addresses that need, and its introduction reinforces our commitment to bringing the most clinically meaningful innovations to the region. We are excited to be partnering with Kent Imaging and look forward to making SnapshotNIR widely accessible across our markets.”

Read the full press release: https://hubs.la/Q04gHNwV0

We’re excited to see Dr. Jeffrey Niezgoda take the stage at the TRSS Conference in Austin, Texas!
05/14/2026

We’re excited to see Dr. Jeffrey Niezgoda take the stage at the TRSS Conference in Austin, Texas!

Address

Suite 300, 1210 8 Street SW
Calgary, AB
T2R1L3

Telephone

+18337335368

Website

Alerts

Be the first to know and let us send you an email when Kent Imaging posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Kent Imaging:

Shortcuts

Share

Category